Fenbendazole — products, DINs, and Canadian availability
This page lists Health Canada–registered pharmaceutical products whose active ingredient list includes Fenbendazole. We track 10 distinct Drug Identification Numbers (DINs) for this molecule, of which 8 are currently in marketed status. Across those registrations there are 3 manufacturers or marketing authorization holders, 5 dosage forms, and 6 distinct strength presentations.
Procurement teams normally arrive here for one of three reasons: a specific brand is unavailable and an equivalent registration is needed; a clinical protocol requires a comparator containing Fenbendazole in a defined strength; or a pharmacy needs to know which manufacturers still hold an active Canadian registration before committing to a substitution. The table below answers the first question directly. For the second and third, Nexara Health can confirm live availability, remaining shelf life, and landed cost from Canadian stock or from any of more than 40 regulated international source markets.
Registration status is not the same as availability. A product can hold marketed status in the Drug Product Database and still be on allocation, discontinued by the holder, or unavailable in the pack size a hospital needs. Where a Fenbendazole product is in shortage, our Canadian drug shortage tracker carries the reported status, the reason where the manufacturer has published one, and the marketed alternatives sharing the same active ingredient.
Dosage forms and strengths recorded for Fenbendazole
Dosage forms: Granules, Suspension, Powder, Paste, Drug Premix. Strengths: 220 MG, 200 MG, 222 MG, 100 MG, 8 G, 10 %.
Manufacturers and marketing authorization holders
NORBROOK LABORATORIES LTD., INTERVET CANADA CORP, LA COOP FEDEREE.
Registered products containing Fenbendazole
| DIN | Product | Manufacturer | Strength | Dosage form | Status |
|---|---|---|---|---|---|
| 02240614 | NOROFEN WORMER | NORBROOK LABORATORIES LTD. | 220 MG | Granules | Cancelled Pre Market |
| 02458535 | PANACUR AQUASOL | INTERVET CANADA CORP | 200 MG | Suspension | Marketed |
| 02297043 | PANACUR GRANULE SINGLES | INTERVET CANADA CORP | 222 MG | Powder | Marketed |
| 00489883 | PANACUR GRANULES 22.2% | INTERVET CANADA CORP | 222 MG | Powder | Marketed |
| 02113163 | PANACUR PASTE 10% | INTERVET CANADA CORP | 100 MG | Paste | Marketed |
| 00489875 | PANACUR SUSPENSION 10% | INTERVET CANADA CORP | 100 MG | Suspension | Marketed |
| 00896543 | PREMELANGE 25/2 PORCS MEDICAMENTE 8GM/KG | LA COOP FEDEREE | 8 G | Drug Premix | Cancelled Post Market |
| 02069490 | SAFE-GUARD PASTE 10% | INTERVET CANADA CORP | 100 MG | Paste | Marketed |
| 00617598 | SAFE-GUARD PREMIX 20% | INTERVET CANADA CORP | 200 MG | Drug Premix | Marketed |
| 02113171 | SAFE-GUARD SUSPENSION 10% | INTERVET CANADA CORP | 10 % | Suspension | Marketed |
Sourcing Fenbendazole through a licensed wholesaler
Nexara Health imports and distributes under Health Canada Drug Establishment Licence #3-002896. For Fenbendazole we can quote Canadian-marketed presentations, equivalent registrations from the EU, UK, US, Switzerland, Australia, and Japan where the Canadian presentation is unavailable, and comparator-grade supply with Certificate of Analysis, batch and expiry records, and full chain of custody for clinical trial use. Cold-chain presentations ship under GDP conditions with continuous temperature monitoring.
Request a quote
Nexara Health is a Health Canada–licensed pharmaceutical wholesaler (DEL #3-002896) based in Winnipeg, Manitoba, supplying hospitals, pharmacies, clinics, CROs, and trial sponsors across Canada. Send us the product, strength, presentation, and quantity for Fenbendazole and we will come back with availability, source market, lead time, and landed cost — usually within 24 hours.
Request a sourcing quote or call +1 (431) 588-9055.